MedDataX Logo

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen

NCT ID: NCT00613314

Last Updated: 2014-05-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15268 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the efficacy and safety of telmisartan-based treatment among patients with metabolic syndrome in actual setting in Philippines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telmisartan in Mild to Moderate Hypertensive Patients

NCT02260089

Hypertension
COMPLETED PHASE4

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

NCT00638911

Hypertension
COMPLETED

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

NCT00471003

Hypertension
COMPLETED

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

NCT05843162

Essential Hypertension Metabolic Syndrome
UNKNOWN PHASE4

Pharmacovigilance and Patient Compliance in Hypertensive Patients

NCT02200575

Hypertension
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Metabolic Syndrome X

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 45 years
* Increased waist circumference (\>88.9cm \[\>35in\] men, \>78.7cm \[\>31in\] for women)
* Elevated triglycerides (\>150mg/dl)
* Low HDL cholesterol (\<40mg/dl in men, \<50mg/dl in women)
* Hypertension (\>130/\>85mmHG)
* Impaired fasting glucose (\>110mg/dl) (8)
* Hypertensive patient assessed to benefit from telmisartan based treatment

Exclusion Criteria

* Hypersensitivity to telmisartan, hydrochlorothiazide (HCTZ) and its excipients
* \<3 months myocardial infarction (MI), stroke or severe heart failure
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site

Alaminos City, Pangasinan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Angeles City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Angeles City, Pampanga, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Antipolo City, Rizal, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Atabay, San Jose, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Bacoor, Cavite, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Baguio City, Benguet, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Balanga City, Bataan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Baliuag, Balacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Baliuag, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Bangued, Abra, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Batac, Ilocos Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Batangas City, Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Batangas City. Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Bauan Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Bautista, Pangasinan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Binan, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Bocaue, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Butuan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Butuan City, Agusan Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cabanatuan City, Nueva Ecija, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cagayan de Oro City, Misamis Oriental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cagayan de Oro City, Misamis, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cagayan de Oro, Misamis Oriental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cainta, Rizal, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Calamba CIty, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Calamba, Misamis Occidental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Calamban City, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Camiling, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cando City, Ilocos Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cauayan City, Isabela, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cavite City, Cavite, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cebu City, Cebu, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

City of Muntinlupa, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Cruz, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Dagupan City, Pangasinan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Dasmarinas, Cavite, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

De Vera, Santiago City, Isabela, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Digolog City, Zamboanga Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Dinalupihan, Bataan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Dipolog City, Zamboange Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ermita, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Espana, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

F Cayco Sampaloc, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Gapan City, Nueva Ecija, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Gingoog City, Misamis Oriental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Greenhills, San Juan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Guagua, Pampanga, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Iba, Zambales, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ibalong, LegazpiCity, Albay, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Igano, Molave, Zamboanga Del Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ilgan City, Lanao Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Iligan City, Lanao Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Iloilo City, Iloilo, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Imus, Cavite, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Kalibo, Aklan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Kalookan City, Tala, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Kaloonkan City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Laoag City, Ilocos Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Laog City, Ilocos Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Lapu-lapu City, Cebu, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Las Pina City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Las Piñas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Legazpi City, Albay, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Lemery, Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Limay, Bataan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Lipa City, Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Lucena City, Quezon, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Makati City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Malate, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Mandaluyong, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Mandaluyong City, Edsa, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Marikina City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Marilao, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Masangkay Tondo, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Meycauayan, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Morayta Sampaloc, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Munoz City, Nueva Ecija, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Naga City, Camarines Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Naga City, Carmarines Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Olonggapo City, Zambales, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ormoc City, Leyte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Oroquita City, Misamis Occidental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ozamis City, Misamis Occidental, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Ozamis City, Misamis, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Paranaque City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Pasay, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Pasig, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Pinamalaayan, Calapan City, Oriental Mindoro, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Pulilan, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Quezon City, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Quezon City, Diliman, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Roxas City, Capiz, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Roxas, Isabela, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Sampaloc, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Carlos City, Pangasinan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Fernanado City, Pampanga, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Fernando City, La Union, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Fernando City, Pampanga, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Miguel, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Pablo City, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

San Pedro, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Santa Cruz, Laguna, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Santa Maria, Bulacan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Santa Maria, Bulaccan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Santiago City, Isabela, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Sorsogon City, Sorsogon, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Surigao City, Surigao Del Norte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Taal, Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tacloban City, Leyte, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Taft Ave, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Taft, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tagbilaran City, Bohol, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tanauan City, Batangas, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tarlac City, Tarlac, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tondo, Manila, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Tuguegarao City, Cagayan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Urdaneta City, Pangasinan, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Valenzuela, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Vigan City, Ilocos Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Vigan City. Ilocos Sur, , Philippines

Site Status

Boehringer Ingelheim Investigational Site

Wawaylan Calocan, , Philippines

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Philippines

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

502.532

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
NCT02242851 COMPLETED
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
NCT03250052 COMPLETED PHASE1
Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.
NCT00750113 COMPLETED PHASE4
Azilsartan Circadian and Sleep Pressure
NCT01762501 COMPLETED NA
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
NCT02238262 COMPLETED
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
NCT02609490 COMPLETED PHASE3
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
NCT00759551 COMPLETED PHASE2
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension
NCT00412932 COMPLETED PHASE4
One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
NCT00695955 COMPLETED PHASE3
Telmisartan Tab Hypertension
NCT00890084 COMPLETED
Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes
NCT01011062 COMPLETED NA
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland
NCT01211171 COMPLETED
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
NCT01289132 COMPLETED PHASE2
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
NCT00696241 COMPLETED PHASE3
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
NCT01033071 COMPLETED PHASE3
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
NCT02059616 UNKNOWN PHASE2
Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
NCT02176850 COMPLETED
Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
NCT00676845 COMPLETED PHASE3
Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®
NCT00927537 COMPLETED
Olmesartan in Essential Hypertension
NCT00185172 COMPLETED PHASE3
Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis
NCT02178306 COMPLETED PHASE4
Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
NCT00362115 COMPLETED PHASE2
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
NCT06168409 COMPLETED PHASE3
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00846365 COMPLETED PHASE3
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
NCT01456169 COMPLETED PHASE3